PRVRX
Price
$12.17
Change
-$0.21 (-1.70%)
Updated
Mar 10 closing price
Net Assets
250.99M
RMFCX
Price
$55.78
Change
-$0.83 (-1.47%)
Updated
Mar 10 closing price
Net Assets
104.15B
Ad is loading...

PRVRX vs RMFCX

Header iconPRVRX vs RMFCX Comparison
Open Charts PRVRX vs RMFCXBanner chart's image
PGIM Quant Solutions Large-Cap Val R
Price$12.17
Change-$0.21 (-1.70%)
VolumeN/A
Net Assets250.99M
American Funds American Mutual R3
Price$55.78
Change-$0.83 (-1.47%)
VolumeN/A
Net Assets104.15B
PRVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRVRX vs. RMFCX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRVRX is a Buy and RMFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. PRVRX (251M). PRVRX pays higher dividends than RMFCX: PRVRX (2.55) vs RMFCX (1.30). PRVRX was incepted earlier than RMFCX: PRVRX (10 years) vs RMFCX (23 years). PRVRX (1.75) is less costly to investors than RMFCX (0.91). PRVRX is a more actively managed with annual turnover of: 81.00 vs. RMFCX (31.00). PRVRX has a lower initial minimum investment than RMFCX: PRVRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 8.37 vs. PRVRX (-4.38). RMFCX return over 5 years is better than : 53.50 vs. PRVRX (27.67).
PRVRXRMFCXPRVRX / RMFCX
Total Expense Ratio1.320.91145%
Annual Report Gross Expense Ratio1.750.91192%
Fund Existence10 years23 years-
Gain YTD1.4753.70040%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets251M104B0%
Annual Yield % from dividends2.551.30196%
Returns for 1 year-4.388.37-52%
Returns for 3 years-6.9919.10-37%
Returns for 5 years27.6753.5052%
Returns for 10 yearsN/A69.15-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FORR10.350.16
+1.57%
Forrester Research
HALO60.980.83
+1.38%
Halozyme Therapeutics
KO71.430.97
+1.38%
Coca-Cola Company
IMAB0.86-0.01
-1.11%
I-MAB
GEO24.01-1.52
-5.95%
GEO Group (The)